Pasithea Therapeutics Corp. — Form 8-K
Filed August 21, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On August 20, 2026, Pasithea Therapeutics Corp. (market cap ~$5.1M) received notice of failure to satisfy continued listing standards (Item 3.01). The filing provides no specific details on which listing rule was violated, remediation plan, or timeline. This is a critical compliance event for a micro-cap biotech company.
Why this rating
Delisting threat is business-altering for micro-cap; threatens capital access, liquidity, and survival.
Extracted items
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.